(19)
(11) EP 1 924 323 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2016 Bulletin 2016/41

(45) Mention of the grant of the patent:
31.08.2016 Bulletin 2016/35

(21) Application number: 06765156.2

(22) Date of filing: 28.07.2006
(51) International Patent Classification (IPC): 
A61N 5/06(2006.01)
(86) International application number:
PCT/GB2006/002841
(87) International publication number:
WO 2007/012875 (01.02.2007 Gazette 2007/05)

(54)

EX VIVO INACTIVATION OF METHICILLIN-RESISTANT STRAPHYLOCOCCUS AUREUS

EX VIVO INAKTIVIERUNG VON METHICILLIN-RESISTENT STRAPHYLOCOCCUS AUREUS

EX VIVO INACTIVATION DE METHICILLIN-RÉSISTANT STRAPHYLOCOCCUS AUREUS


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 29.07.2005 GB 0515550

(43) Date of publication of application:
28.05.2008 Bulletin 2008/22

(73) Proprietor: University of Strathclyde
Glasgow G1 1XQ (GB)

(72) Inventors:
  • ANDERSON, John Galloway
    East Kilbride G74 2JF (GB)
  • MACLEAN, Michelle
    Glasgow G3 8NS (GB)
  • WOOLSEY, Gerald, Alexander
    Graceville, Queensland 4075 (AU)
  • MacGREGOR, Scott John
    Cambulsang, Glasgow G1 1XW (GB)

(74) Representative: Chapman, Paul Gilmour et al
Marks & Clerk LLP Atholl Exchange 6 Canning Street
Edinburgh EH3 8EG
Edinburgh EH3 8EG (GB)


(56) References cited: : 
EP-A1- 0 306 301
WO-A-03/089063
WO-A2-2005/048811
US-A- 4 910 942
US-A1- 2005 055 070
EP-A1- 1 493 820
WO-A2-03/084601
FR-A1- 2 773 715
US-A1- 2004 147 986
US-A1- 2005 107 853
   
  • Osnat Feuerstein ET AL: "Phototoxic Effect of Visible Light on Porphyrornonas gingivalis and Fusobacterium nucleatum: An In Vitro StudyT", Photochemistry and Photobiology, 12 August 2004 (2004-08-12), pages 412-415, XP055098773, [retrieved on 2014-01-28]
  • ASHKENAZI H ET AL: "ERADICATION OF PROPIONIBACTERIUM ACNES BY ITS ENDOGENIC PORPHYRINS AFTER ILLUMINATION WITH HIGH INTENSITY BLUE LIGHT", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, ELSEVIER SCIENCE B.V., AMSTERDAM, NL, vol. 35, 1 January 2003 (2003-01-01), pages 17-24, XP001222030, ISSN: 0928-8244
  • Akira Kawada ET AL: "Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation", Journal of Dermatological Science, vol. 30, no. 2, 1 November 2002 (2002-11-01), pages 129-135, XP055205322, ISSN: 0923-1811, DOI: 10.1016/S0923-1811(02)00068-3
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).